[Androgenetic alopecia. Diagnosis and therapy- a current review].

about

Appraisal of guidelines for androgenetic alopecia using the Appraisal of Guidelines for Research and Evaluation II instrument.Towards a consensus on how to diagnose and quantify female pattern hair loss - The 'Female Pattern Hair Loss Severity Index (FPHL-SI)'.

P2860

Q38949282-21E331E7-7192-46E3-AD98-9AB933CB64A7 Q47938688-E2E63BF2-E87A-4F59-8901-E939DDC447FB

P2860

[Androgenetic alopecia. Diagnosis and therapy- a current review].

Item

http://www.wikidata.org/entity/Q52881974

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

[Androgenetic alopecia. Diagnosis and therapy- a current review].

@en

[Androgenetic alopecia. Diagnosis and therapy- a current review].

@nl

type

Item

label

[Androgenetic alopecia. Diagnosis and therapy- a current review].

@en

[Androgenetic alopecia. Diagnosis and therapy- a current review].

@nl

prefLabel

[Androgenetic alopecia. Diagnosis and therapy- a current review].

@en

[Androgenetic alopecia. Diagnosis and therapy- a current review].

@nl

P1476

[Androgenetic alopecia. Diagnosis and therapy- a current review].

@en

P2093

A Vogt

http://www.w3.org/2001/XMLSchema#string

U Blume-Peytavi

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis of hair disorders.

Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.

The psychological impact of alopecia.

Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.

A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.

Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia

Susceptibility variants for male-pattern baldness on chromosome 20p11.

Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia.

Doctor-patient relations in dermatology: obligations and rights for a mutual satisfaction.

P2888

s00105-013-2579-0

P304

820-829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00105-013-2579-0

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24177664

http://www.w3.org/2001/XMLSchema#string

[Androgenetic alopecia. Diagnosis and therapy- a current review].

about

P2860

P2860

[Androgenetic alopecia. Diagnosis and therapy- a current review].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698